«Previous Article|Table of Contents|Next Article»

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:

2017 02

Page:

220-223

Research Field:

Publishing date:

Info

Title:

Comparative study on traditional Chinese medicine in postoperative triple negative breast cancer prevention and recurrence and metastasis

Author(s):

Zheng Guilan¹; Zhang Jianbin²; Li Xianghong¹; Zhao Yue¹; Li Yingjie³; Li Jianzhu²

1.Department of Oncology;2.Department of Surgical Oncology;3.Combination of Chinese and Western Department,The Fourth Hospital of Qinhuangdao,Hebei Qinhuangdao 066300,China.

Keywords:

traditional Chinese medicine; postoperative triple negative breast cancer; consolidation; recurrence and metastasis

PACS:

R737.9

DOI:

10.3969/j.issn.1672-4992.2017.02.015

Abstract:

Objective:To evaluate whether the consolidation therapy with traditional Chinese medicine after the postoperative chemotherapy or radiotherapy for the triple negative breast cancer can effectively control the recurrence and metastasis and extend the progression-free survival (PFS).Methods:The retrospective control study was conducted in 72 patients after the postoperative chemotherapy or radiotherapy for the triple negative breast cancer,which were divided into 2 groups.The traditional Chinese medical treatment was given for the treatment group after the postoperative western medicine therapy for at least 1.5 years.No special treatment was provided for the control group after the postoperative western medicine therapy,with clinical observation.This group was followed up with recurrence and metastasis.Results:Kaplan -Meier survivorship curve showed that the 3-year PFS in treatment group had more advantages than that in control group.There was statistical difference (P＜0.05).The symptoms were improved markedly (P＜0.05).Conclusion:The "postoperative consolidation therapy of breast cancer" in combination with traditional Chinese medicine under the guidance of TCM after the triple negative breast cancer surgery was beneficial to the survival of patient,improve the symptoms of Chinese medicine and raise the quality of life.However,a further research with more cases is required.

References:

［1］Xing XY,Wei SJ.Characteristics and treatment progress of triple negative breast cancer［J］.J Prac Oncol，2011,26(1):95-98.［邢晓英，魏素菊.三阴乳腺癌的特征及治疗进展［J］.实用肿瘤杂志，2011,26(1):95-98.］
［2］Zhou Y.Clinicopathologic features and prognosis of triple negative breast cancer［J］.Lab Med Clin,2014,11(11):1572-1573.［周勇.三阴型乳腺癌临床病理特征及预后分析［J］.检验医学与临床,2014,11(11):1572-1573.］
［3］Shi YK,Sun Y.Manual of medical oncology［M］.Beijing:People's Medical Publishing House,2016:343-348.［石元凯,孙燕.临床肿瘤内科手册［M］.北京:人民卫生出版社,2016:343-348.］
［4］Chen ZJ.The effect ofsurvival rates about triple negative breast cancer in patients with traditional Chinese medicine［J］.Traditional Med West of Chin,2015,28(9):103-105.［陈志坚.中药治疗对三阴性乳腺癌患者生存率的影响［J］.西部中医药,2015,28(9):103-105.］
［5］Wang YL.Discussion of Chinese medicine treatment of breast cancer［J］.China Pharmaceutical Guide,2015，1(24):182-183.［王艳丽.浅谈中医对乳腺癌的治疗［J］.中国医药指南,2015,1(24):182-183.］
［6］Zheng JB,Shi H,Lin HS.Professor Lin Hongsheng's experience in treating triple negative breast cancer［J］.Lishizhen Med Mater Med Res,2015,26(11):2758-2760.［郑佳彬,石红,林洪生.林洪生教授治疗三阴型乳腺癌经验初探［J］.时珍国医国药,2015,26(11):2758-2760.］
［7］Xu W.The research advances of pathogenesis about breast cancerwith traditional Chinese and Western medicine ［J］.China Modern Doctor,2016,54(5):162-164.［徐炜.乳腺癌中西医病因病机研究及辨证治疗进展［J］.中国现代医生,2016,54(5):162-164.］
［8］Fu Q,Han D,Xu J.Research progress of traditional Chinese medicine therapy in the consolidate period after breast cancer［J］.Beijing J Traditional Chin Med,2010,29(1):75-77.［富琦,韩冬,许金.乳腺癌术后巩固期的中医治疗研究进展［J］.北京中医药,2010,29(1):75-77.］
［9］Lu WP,Jiang CH.Medication rule of ancient prescriptions in the treatment of breast cancer［J］.Chin J Exp Traditional Med Formula，2010,16(3):133-134．［卢雯平，姜翠红.古方治疗乳腺癌的用药规律［J］.中国实验方剂学杂志，2010,16(3):133-134．］
［10］Cui Y,Yao Q,Liu LP,et al.Effect of Yiqi Shengxue formula on bone marrow suppression after adjuvant chemotherapy for breast cancer［J］.J Traditional Chin Med,2014,55(8):684-686.［崔宇,姚嫱,刘利萍,等.益气生血方对乳腺癌患者辅助化疗后骨髓抑制的影响［J］.中医杂志,2014,55(8):684-686.］
［11］Zhou XD,Shu QJ,Xu HH,et al.Effect of Yiqi Jianpi Shugan Formula combined with psychological intervention on quality of life of patients with chemotherapy after breast cancer surgery［J］.J New Chin Med,2013,45(12):121-124.［周旭东,舒琦瑾,徐海虹,等.益气健脾疏肝汤结合心理干预对乳腺癌术后化疗患者生活质量的影响［J］.新中医,2013,45(12):121-124.］
［12］Zhu DL,Lv S.Clinical study on the effect of Fuzheng Xiaoliu Decoction on quality of life and immune function in patients with breast cancer［J］.J New Chin Med,2015,47(2):175-177.［朱冬兰,吕胜.扶正消癥饮调护对乳腺癌术后放化疗患者生存质量的影响［J］.新中医,2015,47(2):175-177.］
［13］Tian HQ,Wang YJ,Wang B,et al.Effect of ruji recipe on the post-surgical survival of female breast cancer patients［J］.Chin J Integrated Traditional and Western Med,2013,33(10):1336-1340.［田华琴,王艳杰,王斌,等.乳积方对女性乳腺癌术后患者生存状况的影响［J］.中国中西医结合杂志,2013,33(10):1336-1340.］
［14］Lu WP,Xu BH.Effect of herbs on progress-free survival in clinical stage II-IV triple negative breast cancer and strategy of traditional chinese medicine［J］.World Chin Med,2013,8(1):53-55.［卢雯平,徐兵和.中药对中晚期三阴乳腺癌的生存影响及中医治疗策略探讨［J］.世界中医药,2013,8(1):53-55.］

Memo

Memo:

秦皇岛市科学技术研究与发展计划任务(编号：201502A156)

Common functions

Last Update: 2016-12-01